| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 08/30/2007 | US20070203223 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease |
| 08/30/2007 | US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol |
| 08/30/2007 | US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors |
| 08/30/2007 | DE102006007883A1 Verfahren zur Herstellung von Menthylamiden A process for preparing menthylamides |
| 08/29/2007 | EP1824837A1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds |
| 08/29/2007 | EP1824827A1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content |
| 08/29/2007 | EP1660469B1 Process for the preparation of 11-(1-piperazinyl)dibenzo 'b, f! '1 ,4!-thiazepine, an intermediate in the synthesis of the antipsychotic drug quetiapine |
| 08/29/2007 | EP1590344A4 Anti-cancer medicaments |
| 08/29/2007 | EP1306083A4 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024626A Intermediate synthesizing compound for preparing atorvastatin calcium |
| 08/29/2007 | CN100334078C Method for synthesizing piperazine |
| 08/28/2007 | US7262296 Substituted aryl alkenoic acid heterocyclic amides |
| 08/28/2007 | US7262220 Antidiabetic agents |
| 08/28/2007 | US7262197 For therapy and prophylaxis of disease or condition in a subject which disease or condition is affected by phospholipase modulation such as restenosis |
| 08/28/2007 | US7262188 Phenyl sulfone derivatives and their use in the treatment of CNS disorders |
| 08/28/2007 | CA2389858C New cyclic derivatives of .alpha.-amino-.gamma.-hydroxy-amides, the process for the preparation thereof and the pharmaceutical compounds which contain them |
| 08/28/2007 | CA2230960C Piperazine derivatives and process for the preparation thereof |
| 08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 08/23/2007 | WO2007093227A1 Pesticide naphthyloxy substituted phenylamidine derivatives |
| 08/23/2007 | WO2007014154A3 10-substituted tetracyclines and methods of use thereof |
| 08/23/2007 | WO2006076452A8 An exo-selective synthesis of himbacine analogs |
| 08/23/2007 | US20070197820 Process for producing urethane (meth)acrylates and new urethane (meth)acrylates |
| 08/23/2007 | US20070197542 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 08/23/2007 | US20070197522 Dpp-iv inhibitors |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197495 Anti-parasitic compounds and methods of their use |
| 08/22/2007 | EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors |
| 08/22/2007 | EP1453804B1 Ccr-3 receptor antagonists vii |
| 08/22/2007 | EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 08/22/2007 | CN1332954C Dipeptidyl peptidase IV effectors |
| 08/22/2007 | CN1332939C Novel compounds inhibiting factor Xa activity |
| 08/22/2007 | CN101022810A Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 08/22/2007 | CN101022806A Use of (4-alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease |
| 08/21/2007 | US7259158 Naphthaline derivatives as H3 inverse agonists |
| 08/16/2007 | WO2007092558A2 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | WO2007092435A2 11-beta hsd1 inhibitors |
| 08/16/2007 | WO2007065261B1 Plasminogen activator inhibitor-1 inhibitors |
| 08/16/2007 | WO2007046513A3 Benzoylurea compounds and use thereof |
| 08/16/2007 | WO2007019397A3 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070191605 Method for the production of ling-chained quaternary ammonium oxalates and ammonium hydrogenoxalates |
| 08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
| 08/16/2007 | US20070191390 Substituted heterocyclic compounds |
| 08/16/2007 | US20070191358 Novel piperidine derivative for the treatment of depression |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191263 Valency platform molecules comprising aminooxy groups |
| 08/16/2007 | US20070189970 Contrast medium for thrombus formation |
| 08/16/2007 | CA2641609A1 11-beta hsd1 inhibitors |
| 08/16/2007 | CA2640229A1 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases |
| 08/15/2007 | EP1817287A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 08/15/2007 | EP1646620B1 Substituted piperidines as histamine h3 receptor ligands |
| 08/15/2007 | EP1569896B1 Tetrahydro-naphthalene derivatives |
| 08/15/2007 | EP1496904B1 Use of pharmaceuticals containing n, n'-disubstituted piperazine compounds |
| 08/15/2007 | EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN1331841C Resveratrol derivative and its production method and uses |
| 08/15/2007 | CN101018774A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 08/15/2007 | CN101016262A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |
| 08/14/2007 | US7257287 Optical interleaver |
| 08/14/2007 | US7256289 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol |
| 08/14/2007 | US7256205 2-Aminothiazole histamine H2 receptor antagonists such as famotidine or nizatidine to which is linked at least one NO and/or NO2 group; treating inflammations including gastrointestinal disorders and reducing the gastrointestinal toxicity associated with the use of NSAIDS |
| 08/14/2007 | US7256204 6-(4-biphenylyl)methoxy-2-(2-(N,N-dimethylamino)ethyl)tetralin for example; inhibiting amyloid-beta protein production; for neurodegenerative diseases such as Alzheimer's disease |
| 08/14/2007 | US7256194 Compounds that inhibit factor Xa activity |
| 08/14/2007 | US7256192 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
| 08/14/2007 | CA2251016C .alpha.1-adrenergic receptor antagonists |
| 08/14/2007 | CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/09/2007 | WO2007088181A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations |
| 08/09/2007 | US20070185127 2-(Arylalkoxy)-1-phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors |
| 08/09/2007 | US20070185110 pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis and hysteromyoma |
| 08/09/2007 | US20070185109 Idene derivatives and process for the preparation thereof |
| 08/09/2007 | US20070185105 Calcium channel blockers |
| 08/09/2007 | US20070185059 Antiallergic agents |
| 08/09/2007 | CA2641817A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparation |
| 08/08/2007 | EP1708992B1 Sulfonamide derivatives for the treatment of diseases |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN1330634C Antibacterial agents |
| 08/08/2007 | CN101014581A Novel piperidine derivative for the treatment of depression |
| 08/08/2007 | CN101014565A Diarylsulfones as 5-HT2a antagonists |
| 08/08/2007 | CN101012208A Process for preparing N-methyl morpholine |
| 08/08/2007 | CN101012170A N-arylation method in water solution |
| 08/07/2007 | US7253207 Quinones as disease therapies |
| 08/07/2007 | US7253185 Amino ceramide-like compounds and therapeutic methods of use |
| 08/07/2007 | US7253173 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253157 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 08/07/2007 | US7253007 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 08/07/2007 | CA2221689C Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 08/02/2007 | WO2007087585A1 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 08/02/2007 | WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS |
| 08/02/2007 | WO2007086471A1 Process for production of lasofoxifene or analogue thereof |
| 08/02/2007 | WO2007085729A2 Novel method for synthesis of 1,4-morpholine-2,5-diones |
| 08/02/2007 | WO2007070760A3 Compounds which modulate the cb2 receptor |
| 08/02/2007 | WO2007066163A3 Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates |
| 08/02/2007 | US20070179297 Chemical compounds |